Ultragenyx Pharmaceutical Inc. (RARE): Shares Outstanding
96.60M
As of 2025-12-31
98.60M
As of 2026-06-30
+11.2%
3-year compound annual growth
+7.7%
5-year compound annual growth
+9.5%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 96.60M | +4.4% | 2026-02-18, Balance as of period end |
| 2024-12-31 | 92.50M | +12.4% | 2026-02-18, Balance as of period end |
| 2023-12-31 | 82.32M | +17.3% | 2025-02-19, Balance as of period end |
| 2022-12-31 | 70.20M | +1.2% | 2024-02-21, Balance as of period end |
| 2021-12-31 | 69.34M | +3.8% | 2023-02-17, Balance as of period end |
| 2020-12-31 | 66.82M | +15.5% | 2022-02-15, Balance as of period end |
| 2019-12-31 | 57.84M | +13.7% | 2021-02-12, Balance as of period end |
| 2018-12-31 | 50.86M | +15.2% | 2020-02-14, Balance as of period end |
| 2017-12-31 | 44.17M | +7.1% | 2019-02-20, Balance as of period end |
| 2016-12-31 | 41.24M | +6.1% | 2018-02-21, Balance as of period end |
| 2015-12-31 | 38.88M | +21.8% | 2017-02-17, Balance as of period end |
| 2014-12-31 | 31.93M | +747.9% | 2016-02-26, Balance as of period end |
| 2013-12-31 | 3.77M | n/a | 2015-03-27, Balance as of period end |